Zeta Pharma is an Egyptian pharmaceutical company established in 2010, operating as a manufacturer, wholesaler, distributor, and service provider, with a focus on localizing the pharmaceutical industry and offering advanced therapeutic solutions. Acquired by El-Banna Group in 2016, the company has grown significantly, employing between 501 and 1000 people. Zeta Pharma operates a state-of-the-art factory in Sadat City, spanning 7605 to 8000 square meters, equipped with four production lines for tablets and syringes, built to WHO cGMP standards. They hold GMP certification and are in the process of achieving European GMP accreditation. The company specializes in a comprehensive range of branded generic pharmaceuticals, including extended-release capsules, film-coated tablets, and powder for oral suspension. Their product portfolio covers various therapeutic areas such as Gastrointestinal, Hepatitis C, Neuropsychological, Cardiovascular, Gynecology, Antimicrobial drugs, as well as supplements and cosmetics. Key products include Alzazonex, Influbavir, Levofloxacin, Epilosamide, Nexicure Plus, Empacoza, Elimbosis, and Vonseca. Zeta Pharma also provides contract manufacturing (Toll Manufacturing) and Private Label services. They are a significant supplier to the Ministry of Health and have an international presence, exporting VIRC drugs to Armenia, Ukraine, Eastern Europe, and East Asia, and serving markets across Africa, Central America, East Asia, Europe, the Middle East, South America, and South East Asia. In 2024, they expanded their presence to Saudi Arabia through a joint venture, Zeta Gulf.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High capacity factoryCan handle large-scale or bulk production orders.
Industry association memberMember of International Egyptian Orthopedic Association (EOA) association.
Contact
**********************
2
*******************
2
Customers
MULISA
4 shipments
*********************
No shipments
*******************
No shipments
*******************
No shipments
******************
No shipments
Unlock all 5 customers
Unlock
Certifications
GMP
4
Good Manufacturing Practice
Ask AI about this supplier
Curious about this supplier? Ask AI for a quick overview.
Key export market
EuropeEurope
AsiaAsia
AfricaAfrica
🇦🇲 Armenia🇦🇲 Armenia
🇺🇦 Ukraine🇺🇦 Ukraine
🇲🇪 Montenegro🇲🇪 Montenegro
🇸🇦 Saudi Arabia🇸🇦 Saudi Arabia
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customers
Top 5 customers
This insight is only available in the Pro plan
Top 5 export countries
Reflecting the supplier's export experience in target countries
Top 5 export countries
This insight is only available in the Pro plan
Shipment count distribution
Reflecting the supplier's market business activity
All categories
Loading chart data...
Shipment count distribution
This insight is only available in the Pro plan
Export weight distribution (kg)
Reflecting the supplier's export scale
All categories
Loading chart data...
Export weight distribution (kg)
This insight is only available in the Pro plan
Export weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughs
All categories
Loading chart data...
Export weight trend (kg)
This insight is only available in the Pro plan
CIF trend (USD)
For identifying high-value cooperation periods and single order value changes
All categories
Loading chart data...
CIF trend (USD)
This insight is only available in the Pro plan
Similar suppliers you may like
Zydus Lifesciences Ltd
🇮🇳 India
More than 10000 peopleManufacturer
High capacity factory
Large enterprise group
Own brand
OEM manufacturer
Shipments
12133
Key customer
EVERSANA LIFE SCIENCE
Key market
🇺🇸 United States
Description
Zydus Lifesciences Ltd, also known as Cadila Healthcare Ltd, is a leading global pharmaceutical manufacturer headquartered in Ahmedabad, India. Ranking 4th in the Indian pharmaceutical industry, the company operates a vast network of over 30 manufacturing plants across India, the US, and Brazil. With a workforce exceeding 29,000 employees and a dedicated research team of 1,500 scientists, the company specializes in a diverse range of healthcare solutions including New Chemical Entities (NCEs), vaccines, biosimilars, and complex formulations such as transdermal patches and topical medications. Their extensive product portfolio covers critical therapeutic areas such as oncology, cardio-metabolic diseases, neurosciences, and inflammation. Notable innovations include TwinrabTM, the world's first biosimilar of Adalimumab (Exemptia), and India's first tetravalent inactivated influenza vaccine. As an OEM provider with significant manufacturing capabilities, Zydus Lifesciences serves regulated markets in the US and Europe, as well as high-growth regions in Latin America, South Africa, and over 25 emerging markets worldwide.